エピソード

  • Nobels, Nitrogen, Nutrition: The Nexus of Science and Industry (pt. 2)
    2024/12/15

    In this episode of ⁠⁠SIGNET⁠⁠, we distill three transformative moments in science and industry into just 19 minutes. From Fritz Haber and Carl Bosch’s ammonia synthesis that fed billions and armed nations, to the discovery of penicillin and the global collaboration that made it a lifesaver, to Norman Borlaug’s Green Revolution and its lasting impact on humanity—this episode delivers the highlights of innovation and consequence.

    Perfect for curious minds short on time. Tune in now at ⁠⁠significant-podcast.com⁠⁠.

    続きを読む 一部表示
    19 分
  • Catalysts and Craters: The Collision of Science and Industry (Pt. 1)
    2024/12/11

    We explore two astonishing tales where science and industry collided with world-altering consequences. First, the untold story of how Pemex geologists uncovered clues to the Chicxulub impact crater decades before its role in the extinction of the dinosaurs was recognized—a discovery delayed by corporate priorities and scientific blind spots. Then, we delve into the legacy of Thomas Midgley Jr., whose groundbreaking innovations in tetraethyl lead and CFCs solved pressing problems of his time but left catastrophic environmental and public health legacies. These stories reveal the uneasy, often dangerous, partnership between science and industry and the unintended consequences that have shaped our world.


    Learn more at https://significant-podcast.com.

    続きを読む 一部表示
    14 分
  • Tackling CTE: Inside the NFL’s Concussion Crisis
    2024/11/17

    Signet distills the latest episode of Significant, where Dr. David Filippi - and his AI friends - explore the NFL’s concussion crisis. From the science, to the personal stories, to the cultural shifts impacting the game, it's all here - in 13 minutes. For the full experience, visit significant-podcast.com.


    Note: Signet is an AI-generated summary of the Significant Podcast and may contain amusing or unexpected errors.

    続きを読む 一部表示
    12 分
  • Should Everybody Be On A GLP-1?
    2024/11/03

    Semaglutide and tirzepatide have reshaped diabetes and weight-loss treatment, but could these drugs hold even greater potential? Join Dr. David S. Filippi—and his AI friends—on a quick journey into emerging data, revealing mechanisms, benefits, and mysteries of these breakthrough medications. Are they the most significant drugs of our time? Listen in and decide. Visit us at significant-podcast.com.

    Note: Signet is a brief, AI-generated summary of the Significant Podcast and may contain amusing or unexpected errors.

    続きを読む 一部表示
    13 分